Cargando…
The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis
PURPOSE: Elective pelvic lymph node radiotherapy (PLNRT) in prostate cancer is often omitted from definitive (n = 267) and post prostatectomy (n = 160) radiotherapy (RT) due to concerns regarding toxicity and efficacy. Data comparing patient-reported outcome measures (PROMs) with or without PLNRT is...
Autores principales: | Jensen, Garrett L., Jhavar, Sameer G., Ha, Chul S, Hammonds, Kendall P., Swanson, Gregory P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256976/ https://www.ncbi.nlm.nih.gov/pubmed/35813937 http://dx.doi.org/10.1016/j.ctro.2022.06.008 |
Ejemplares similares
-
C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation
por: Jensen, Garrett L, et al.
Publicado: (2021) -
Reference Results for Blood Parameter Changes and Recovery after Pelvic Radiation without Chemotherapy
por: Swanson, Gregory P., et al.
Publicado: (2022) -
The effect of pelvic radiation alone on lymphocyte subgroups
por: Swanson, Gregory P., et al.
Publicado: (2020) -
Elective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity
por: Murthy, Vedang, et al.
Publicado: (2017) -
Dose escalated simultaneous integrated boost of gross nodal disease in gynecologic cancers: a multi-institutional retrospective analysis and review of the literature
por: Jensen, Garrett Lee, et al.
Publicado: (2021)